Treatment of lower urinary tract obstruction (LUTO) with the SOMATEX® Intra Uterine Shunt
Interesting and new results for the SOMATEX® Intra Uterine Shunt have been presented on the 15th World Congress in Fetal Medicine in Mallorca by Professor Geipel from the University of Bonn, Germany.
In this study, the authors concluded that vesicoamniotic shunting < 17+0 weeks with the SOMATEX® Intra Uterine Shunt is feasible and associated with a low rate of early dislocation. Vesicoamniotic shunting offers an improved chance of survival, with low pulmonary morbidity. Risk of progression to renal failure pre- or postnatally is still significant. Please do not hesitate to contact us in case you need further information, we will let you know as soon as the published abstract is available.
Exhibitor Data Sheet